Skip to content

Author

Georgios Georgiopoulos

We have 3 of 24 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Estimated pulse wave velocity and 20-year cumulative incidence of type 2 diabetes: The ATTICA cohort study (2002-2022).

AIMS Estimated pulse wave velocity (ePWV), a composite marker derived from age and mean blood pressure, reflects integrated vascular ageing and haemodynamic load. This study aimed to investigate the association between baseline ePWV and the 20-year cumulative incidence of type 2 diabetes (T2D) in a population-based coh...

Ioanna Kechagia, C. Chrysohoou, Georgios Georgiopoulos et al. · 0 citations
Open access Aug 2026

Association of non-invasive liver-related scores with cardiovascular disease and a four-domain cardiovascular–renal–hepatic–metabolic phenotype in patients with type 2 diabetes mellitus and MASLD

Metabolic dysfunction–associated steatotic liver disease (MASLD) is a systemic disorder associated with cardiovascular, renal, and metabolic comorbidities. We evaluated cardiovascular disease (CVD), four-domain cardiovascular–renal–hepatic–metabolic (CRHM) involvement, and their associations with non-invasive liver-rel...

K. Stefanaki, Dimitrios S. Karagiannakis, Maria Manolakopoulou et al. · 0 citations
Apr 2026

Statin Intensification and LDL Cholesterol Reduction are Associated with Longitudinal Changes in Circulating Amyloid-β 1–40 in a Prospective Dyslipidemia Cohort

In high-risk patients, statin initiation or intensification is associated with a short-term increase, followed by a long-term return to initial Aβ40 circulating levels, whereas patients achieving LDL-C reduction show long-term stabilization of Aβ40 levels.

E. Aivalioti, Georgios Georgiopoulos, D. Delialis et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.